SBC vs INMD

For growth investors, SBC Medical Group Holdings Incorporated (SBC) is the stronger pick with 6.

1% revenue growth year-over-year, versus -6. 2% for InMode Ltd. (INMD). SBC Medical Group Holdings Incorporated (SBC) offers the better valuation at 6. 7x trailing P/E (7. 1x forward), making it the more compelling value choice. Analysts rate SBC Medical Group Holdings Incorporated (SBC) a "Buy" — based on 1 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, SBC Medical Group Holdings Incorporated (SBC) is the cheapest at 6.

7x versus InMode Ltd. at 9. 5x. On forward P/E, SBC Medical Group Holdings Incorporated is actually cheaper at 7. 1x.

Over the past 5 years, InMode Ltd.

(INMD) delivered a total return of -63. 9%, compared to -67. 7% for SBC Medical Group Holdings Incorporated (SBC). Over 10 years, the gap is even starker: INMD returned +100. 1% versus SBC's -67. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), SBC Medical Group Holdings Incorporated (SBC) is the lower-risk stock at 0.

76β versus InMode Ltd. 's 1. 04β — meaning INMD is approximately 37% more volatile than SBC relative to the S&P 500. On balance sheet safety, InMode Ltd. (INMD) carries a lower debt/equity ratio of 2% versus 6% for SBC Medical Group Holdings Incorporated — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), SBC Medical Group Holdings Incorporated (SBC) is pulling ahead at 6.

1% versus -6. 2% for InMode Ltd. (INMD). On earnings-per-share growth, the picture is similar: SBC Medical Group Holdings Incorporated grew EPS 15. 5% year-over-year, compared to -36. 4% for InMode Ltd.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

InMode Ltd.

(INMD) is the more profitable company, earning 25. 3% net margin versus 22. 7% for SBC Medical Group Holdings Incorporated — meaning it keeps 25. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SBC leads at 34. 2% versus 23. 0% for INMD. At the gross margin level — before operating expenses — INMD leads at 78. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, SBC Medical Group Holdings Incorporated (SBC) trades at 7.

1x forward P/E versus 9. 4x for InMode Ltd. — 2. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for SBC: 179. 5% to $9. 00.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, SBC Medical Group Holdings Incorporated (SBC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

76)). Both have compounded well over 10 years (SBC: -67. 7%, INMD: +100. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (SBC (Industrials) and INMD (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.